Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep disorders in hemodialysis patients
IRCT20220112053698N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of melatonin in sleep disorder (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Sleep quality and Respiratory apnea. Started Feb 2022; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on IRCT20220112053698N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220112053698N1.